Differential cellular immune responses to wild-type and attenuated edmonston tag measles virus strains are primarily defined by the viral phosphoprotein gene

Journal of Medical Virology

Volumn 82, Issue 11, 2010, Pages 1966-1975

  Haralambieva, Iana H ^a   Ovsyannikova, Inna G ^a   Dhiman, Neelam ^a   Vierkant, Robert A ^a   Jacobson, Robert M ^a   Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cellular immunity; Cytokines; Gene expression; Measles virus; MMR vaccine; P gene

Indexed keywords

CYTOKINE; LIVE VACCINE; MEASLES VACCINE; P PROTEIN, SENDAI VIRUS; PHOSPHOPROTEIN; VIRUS PROTEIN;

ADOLESCENT; ARTICLE; CELL LINE; CELLULAR IMMUNITY; GENE EXPRESSION PROFILING; GENETICS; HUMAN; IMMUNE EVASION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MEASLES; MEASLES VIRUS; METABOLISM; T LYMPHOCYTE; VIROLOGY;

ADOLESCENT; CELL LINE; CYTOKINES; GENE EXPRESSION PROFILING; HUMANS; IMMUNE EVASION; IMMUNITY, CELLULAR; LYMPHOCYTE ACTIVATION; MEASLES; MEASLES VACCINE; MEASLES VIRUS; PHOSPHOPROTEINS; T-LYMPHOCYTES; VACCINES, ATTENUATED; VIRAL PROTEINS;

EID: 79952116256     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21899     Document Type: Article

References (54)

1. Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, Randall RE. 2004. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci USA 101: 17264-17269.
2. Berghall H, Siren J, Sarkar D, Julkunen I, Fisher PB, Vainionpaa R, Matikainen S. 2006. The interferon-inducible RNA helicase, mda-5, is involved in measles virus-induced expression of antiviral cytokines. Microbes Infect 8: 2138-2144.
3. Bieback K, Lien E, Klagge IM, Avota E, Schneider-Schaulies J, Duprex WP, Wagner H, Kirschning CJ, Ter Meulen V, Schneider-Schaulies S. 2002. Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol 76: 8729-8736.
4. Bouche FB, Ertl OT, Muller CP. 2002. Neutralizing B cell response in measles. Viral Immunol 15: 451-471.
5. Caignard G, Guerbois M, Labernardiere JL, Jacob Y, Jones LM, Infectious Mapping Project I-MAP, Wild F, Tangy F, Vidalain PO, 2007. Measles virus V protein blocks Jak1-mediated phosphorylation of STAT1 to escape IFN-alpha/beta signaling. Virology 368: 351-362.
6. Carsillo M, Klapproth K, Niewiesk S. 2009. Cytokine imbalance after measles virus infection has no correlation with immune suppression. J Virol 83: 7244-7251.
7. Chabalgoity JA, Baz A, Rial A, Grille S. 2007. The relevance of cytokines for development of protective immunity and rational design of vaccines. Cytokine Growth Factor Rev 18: 195-207.
8. Childs K, Stock N, Ross C, Andrejeva J, Hilton L, Skinner M, Randall R, Goodbourn S. 2007. MDA-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 359: 190-200.
9. Childs KS, Andrejeva J, Randall RE, Goodbourn S. 2009. Mechanism of MDA-5 inhibition by paramyxovirus V proteins. J Virol 83: 1465-1473.
10. Devaux P, Hodge G, McChesney MB, Cattaneo R. 2008. Attenuation of V- or C-defective measles viruses: Infection control by the inflammatory and interferon responses of rhesus monkeys. J Virol 82: 5359-5367.
11. Devaux P, von Messling V, Songsungthong W, Springfeld C, Cattaneo R. 2007. Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1 phosphorylation. Virology 360: 72-83.
12. Dhiman N, Ovsyannikova IG, Ryan JE, Jacobson RM, Vierkant RA, Pankratz SV, Jacobsen SJ, Poland GA. 2005. Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following MMR-II vaccination. Clin Exp Immunol 142: 498-504.
13. Duprex WP, McQuaid S, Hangartner L, Billeter MA, Rima BK. 1999. Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus. J Virol 73: 9568-9575.
14. Fontana JM, Bankamp B, Bellini WJ, Rota PA. 2008. Regulation of interferon signaling by the C and V proteins from attenuated and wild-type strains of measles virus. Virology 374: 71-81.
15. Garcia-Sastre A, Biron CA. 2006. Type 1 interferons and the virus-host relationship: A lesson in detente. Science 312: 879-882.
16. Gerlier D, Valentin H. 2009. Measles virus interaction with host cells and impact on innate immunity. In: Griffin DE, Oldstone MB, editors. Measles-History and basic biology. Berlin, Heidelberg: Springer-Verlag. pp 163-191.
17. Gotoh B, Komatsu T, Takeuchi K, Yokoo J. 2002. Paramyxovirus strategies for evading the interferon response. Rev Med Virol 12: 337-357.
18. Griffin DE, Ward BJ. 1993. Differential CD4 T cell activation in measles. J Infect Dis 168: 275-281.
19. Griffin DE, Ward BJ, Esolen LM. 1994. Pathogenesis of measles virus infection: An hypothesis for altered immune responses. J Infect Dis 170: S24-S31.
20. Hahm B. 2009. Hostile communication of measles virus with host innate immunity and dendritic cells. Curr Top Microbiol Immunol 330: 271-287.
21. Hahm B, Cho JH, Oldstone MB. 2006. Measles virus-dendritic cell interaction via SLAM inhibits innate immunity: Selective signaling through TLR4 but not other TLRs mediates suppression of IL-12 synthesis. Virology 358: 251-257.
22. Haralambieva I, Iankov I, Hasegawa K, Harvey M, Russell SJ, Peng KW. 2007. Engineering oncolytic measles virus to circumvent the intracellular innate immune response. Mol Ther 15: 588-597.
23. Howe RC, Dhiman N, Ovsyannikova IG, Poland GA. 2005a. Induction of CD4 T cell proliferation and Th1-like cytokine responses in vitro to measles virus. Clin Exp Immunol 140: 333-342.
24. Howe RC, Ovsyannikova IG, Pinsky NA, Poland GA. 2005b. Identification of Th0 cells responding to measles virus. Hum Immunol 66: 104-115.
25. Larosa DF, Orange JS. 2008. 1. Lymphocytes. J Allergy Clin Immunol 121: S364-S369.
26. Moss WJ, Ryon JJ, Monze M, Griffin DE. 2002. Differential regulation of interleukin (IL)-4, IL-5, and IL-10 during measles in Zambian children. J Infect Dis 186: 879-887.
27. Nakatsu Y, Takeda M, Iwasaki M, Yanagi Y. 2009. A highly attenuated measles virus vaccine strain encodes a fully functional C protein. J Virol 83: 11996-12001.
28. Nakatsu Y, Takeda M, Ohno S, Koga R, Yanagi Y. 2006. Translational inhibition and increased interferon induction in cells infected with C protein-deficient measles virus. J Virol 80: 11861-11867.
29. Nanan R, Rauch A, Kämpgen E, Niewiesk S, Kreth HW. 2000. A novel sensitive approach for frequency analysis of measles virus-specific memory T-lymphocytes in healthy adults with a childhood history of natural measles. J Gen Virol 81: 1313-1319.
30. Naniche D. 2009. Human immunology of measles virus infection. Curr Top Microbiol Immunol 330: 151-171.
31. Naniche D, Yeh A, Eto D, Manchester M, Friedman RM, Oldstone BA. 2000. Evasion of host defenses by measles virus: Wild-type measles virus infection interferes with induction of Alpha/Beta interferon production. J Virol 74: 7478-7484.
32. Ohno S, Ono N, Takeda M, Takeuchi K, Yanagi Y. 2004. Dissection of measles virus V protein in relation to its ability to block alpha/beta interferon signal transduction. J Gen Virol 85: 2991-2999.
33. Ono N, Tatsuo H, Hidaka Y, Tomonobu A, Minagawa H, Yanagi Y. 2001. Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J Virol 75: 4399-4401.
34. Ovsyannikova IG, Jacobson RM, Vierkant RA, Jacobsen SJ, Pankratz VS, Poland GA. 2004. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum Immunol 65: 1506-1515.
35. Ovsyannikova IG, Reid KC, Jacobson RM, Oberg AL, Klee GG, Poland GA. 2003. Cytokine production patterns and antibody response to measles vaccine. Vaccine 21: 3946-3953.
36. Ovsyannikova IG, Ryan JE, Vierkant RA, Pankratz SV, Jacobson RM, Poland GA. 2005. Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responses. Immunogenetics 57: 828-836.
37. Palosaari H, Parisien JP, Rodriguez JJ, Ulane CM, Horvath CM. 2003. STAT protein interference and suppression of cytokine signal transduction by measles virus V protein. J Virol 77: 7635-7644.
38. Ramachandran A, Parisien JP, Horvath CM. 2008. STAT2 is a primary target for measles virus V protein-mediated alpha/beta interferon signaling inhibition. J Virol 82: 8330-8338.
39. Randall RE, Goodbourn S. 2008. Interferons and viruses: An interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89: 1-47.
40. Ryan JE, Ovsyannikova IG, Dhiman N, Pinsky NA, Vierkant RA, Jacobson RM, Poland GA. 2005. Inter-operator variation in ELISPOT analysis of measles virus-specific IFN-gamma secreting T cells. Scand J Clin Lab Invest 65: 681-690.
41. Schneider-Schaulies S, Dittmer U. 2006. Silencing T cells or T-cell silencing: Concepts in virus-induced immunosuppression. J Gen Virol 87: 1423-1438.
42. Shaffer JA, Bellini WJ, Rota PA. 2003. The C protein of measles virus inhibits the type I interferon response. Virology 315: 389-397.
43. Steinman L. 2007. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13: 139-145.
44. Svitek N, von Messling V. 2007. Early cytokine mRNA expression profiles predict Morbillivirus disease outcome in ferrets. Virology 362: 404-410.
45. Takeda M, Takeuchi K, Miyajima N, Kobune F, Ami Y, Nagata N, Suzaki Y, Nagai Y, Tashiro M. 2000. Recovery of pathogenic measles virus from cloned cDNA. J Virol 74: 6643-6647.
46. Takeuchi K, Kadota SI, Takeda M, Miyajima N, Nagata K. 2003. Measles virus V protein blocks interferon (IFN)-alpha/beta but not IFN-gamma signaling by inhibiting STAT1 and STAT2 phosphorylation. FEBS Lett 545: 177-182.
47. Takeuchi K, Takeda M, Miyajima N, Ami Y, Nagata N, Suzaki Y, Shahnewaz J, Kadota S, Nagata K. 2005. Stringent requirement for the C protein of wild-type measles virus for growth both in vitro and in macaques. J Virol 79: 7838-7844.
48. van Els CA, Nanan R. 2002. T cell responses in acute measles. Viral Immunol 15: 435-450.
49. Ward BJ, Griffin DE. 1993. Changes in cytokine production after measles virus vaccination: Predominant production of IL-4 suggests induction of a Th2 response. Clin Immunol Immunopathol 67: 171-177.
50. Wu VH, McFarland H, Mayo K, Hanger L, Griffin DE, Dhib-Jalbut S. 1993. Measles virus-specific cellular immunity in patients with vaccine failure. J Clin Microbiol 31: 118-122.
51. Yanagi Y, Takeda M, Ohno S. 2006. Measles virus: Cellular receptors, tropism and pathogenesis. J Gen Virol 87: 2767-2779.
52. Yu XL, Cheng YM, Shi BS, Qian FX, Wang FB, Liu XN, Yang HY, Xu QN, Qi TK, Zha LJ, Yuan ZH, Ghildyal R. 2008. Measles virus infection in adults induces production of IL-10 and is associated with increased CD4+ CD25+ regulatory T cells. J Immunol 181: 7356-7366.
53. Zilliox MJ, Moss WJ, Griffin DE. 2007. Gene expression changes in peripheral blood mononuclear cells during measles virus infection. Clin Vaccine Immunol 14: 918-923.
54. Zilliox MJ, Parmigiani G, Griffin DE. 2006. Gene expression patterns in dendritic cells infected with measles virus compared with other pathogens. Proc Natl Acad Sci USA 103: 3363-3368.